Publications

Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

 60
Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

Tags:

Previous Article

Post Translation Modification

Next Article

Treatment of IL-18-binding protein biologics to treat liver disease

Related Posts

Regional brain volume changes in Hakim’s disease versus Alzheimer’s and mild cognitive impairment

Regional brain volume changes in Hakim’s disease versus...

 374

A hierarchical model of early brain functional network development

A hierarchical model of early brain functional network ...

 116

Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation

Sweetener aspartame aggravates atherosclerosis through ...

 39